EMN vs PATH
Eastman Chemical Company (EMN) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the EMN and PATH stock pages for the full models.
Not investment advice.